Select a section from the left sidebar
Browniine
- Family: Plantae - Ranunculaceae
- Kingdom: Plantae
-
Class: Alkaloid
- Subclass: Norditerpenoid Alkaloid
Canonical Smiles | COCC12CCC(C34C2C(OC)C(C3N(C1)CC)(O)C1(C2C4CC(C2O)C(C1)OC)O)OC |
---|---|
InChI | InChI=1S/C25H41NO7/c1-6-26-11-22(12-30-2)8-7-16(32-4)24-14-9-13-15(31-3)10-23(28,17(14)18(13)27)25(29,21(24)26)20(33-5)19(22)24/h13-21,27-29H,6-12H2,1-5H3 |
InChIKey | MODXUQZMEBLSJD-UHFFFAOYSA-N |
Formula | C25H41NO7 |
HBA | 8 |
HBD | 3 |
MW | 467.6 |
Rotatable Bonds | 6 |
TPSA | 100.85 |
LogP | 0.27 |
Number Rings | 6 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Fraction CSP3 | 1.0 |
Exact Mass | 467.29 |
Number of Lipinski Rule Violations | 0 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Delphinium leroyi | Ranunculaceae | Plantae | 1127171 |
Showing of synonyms
Browniine
5140-42-1
20-ethyl-1,6,16-trimethoxy-4-(methoxymethyl)aconitane-7,8,14-triol
DTXSID30965719
FAA14042
NSC333055
NSC-333055
No compound-protein relationship available.
SMILES: C1C(C2)CCC(C2C1C345)C6C3NCC(C4C6)CCC5
Level: 0
Mol. Weight: 467.6 g/mol
No bioactivities available.
Absorption
- Caco-2 (logPapp)
- -5.34
- Human Oral Bioavailability 20%
- Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- -5.140
- Human Oral Bioavailability 50%
- Bioavailable
- P-Glycoprotein Inhibitor
- Non-Inhibitor
- P-Glycoprotein Substrate
- Non-Substrate
- Skin Permeability
- -0.87
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Non-Penetrable
- Fraction Unbound (Human)
- 0.380
- Plasma Protein Binding
- 6.18
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Non-Inhibitor
- CYP 1A2 Inhibitor
- Non-Inhibitor
- CYP 1A2 Substrate
- Non-Substrate
- CYP 2C19 Inhibitor
- Non-Inhibitor
- CYP 2C19 Substrate
- Non-Substrate
- CYP 2C9 Inhibitor
- Non-Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Substrate
- OATP1B1
- Non-Inhibitor
- OATP1B3
- Non-Inhibitor
Excretion
- Clearance
- 4.780
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Safe
- Bee
- Toxic
- Bioconcentration Factor
- -0.210
- Biodegradation
- Safe
- Carcinogenesis
- Safe
- Crustacean
- Safe
- Liver Injury I (DILI)
- Safe
- Eye Corrosion
- Safe
- Eye Irritation
- Safe
- Maximum Tolerated Dose
- -1.140
- Liver Injury II
- Safe
- hERG Blockers
- Safe
- Daphnia Maga
- 6.260
- Micronucleos
- Safe
- NR-AhR
- Safe
- NR-AR
- Safe
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Safe
- NR-PPAR-gamma
- Safe
- NR-TR
- Safe
- T. Pyriformis
- -201.960
- Rat (Acute)
- 3.890
- Rat (Chronic Oral)
- 2.640
- Fathead Minnow
- 3.310
- Respiratory Disease
- Toxic
- Skin Sensitisation
- Safe
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Safe
- SR-p53
- Safe
General Properties
- Boiling Point
- 410.350
- Hydration Free Energy
- -3.130
- Log(D) at pH=7.4
- 1.580
- Log(P)
- 1.03
- Log S
- -2.08
- Log(Vapor Pressure)
- -8.73
- Melting Point
- 185.3
- pKa Acid
- 6.65
- pKa Basic
- 7.61
No predicted protein targets found for this compound.